QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NASDAQ:FTXH

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News

$25.86
+0.08 (+0.31%)
(As of 02:22 PM ET)
Today's Range
$25.73
$25.86
50-Day Range
$25.78
$28.34
52-Week Range
$23.85
$28.41
Volume
1,159 shs
Average Volume
6,521 shs
Market Capitalization
$19.40 million
Assets Under Management
$19.32 million
Dividend Yield
1.47%
Net Expense Ratio
0.60%
FTXH stock logo

About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

FTXH Stock Price History

FTXH ETF News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Solid Q4 Earnings Fail to Impress Pharma ETFs
See More Headlines
Receive FTXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
First Trust
Fund Name
First Trust Nasdaq Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:FTXH
Inception Date
9/20/2016
Fund Manager
Daniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq US Smart Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
51

Fund Statistics

Assets Under Management
$19.32 million
Average Daily Volume
$2,603.50
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Old Mission

Options

Optionable
N/A
Short Interest
1,000 shs

Miscellaneous

Beta
0.70
Creation Unit
50,000
Creation Fee
$500.00
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

First Trust Nasdaq Pharmaceuticals ETF Expenses

TypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.60%0.56%0.54%0.48%0.51%
Other Expenses0.00%0.40%0.54%0.34%0.58%
Total Expense0.60%0.72%0.70%0.58%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%
Net Expense0.60%0.60%0.60%0.54%0.58%

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings & Exposure

FTXH Sector Exposure

FTXH Industry Exposure


FTXH ETF - Frequently Asked Questions

How have FTXH shares performed in 2024?

First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.62 at the start of the year. Since then, FTXH shares have decreased by 3.3% and is now trading at $25.73.
View the best growth stocks for 2024 here
.

How often does First Trust Nasdaq Pharmaceuticals ETF pay dividends? What is the dividend yield for First Trust Nasdaq Pharmaceuticals ETF?

First Trust Nasdaq Pharmaceuticals ETF announced a dividend on Wednesday, March 20th. Stockholders of record on Friday, March 22nd will be given a dividend of $0.0676 per share on Thursday, March 28th. The ex-dividend date is Thursday, March 21st.
Read our dividend analysis for FTXH
.

What does FTXH invest in?

First Trust Nasdaq Pharmaceuticals ETF is a equity fund issued by First Trust. FTXH focuses on health care investments and follows the Nasdaq US Smart Pharmaceuticals Index. The fund's investments total to approximately $19.32 million assets under management.

What stocks does First Trust Nasdaq Pharmaceuticals ETF hold?
What is the management fee for First Trust Nasdaq Pharmaceuticals ETF?

First Trust Nasdaq Pharmaceuticals ETF's management fee is 0.60% and has no other recorded expenses or fee waivers. The net expense ratio for FTXH is 0.60%.

What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Auxly Cannabis Group (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC), BioCorRx (BICX), BlackRock Municipal Income Trust (BFK), AmeriGas Partners (APU) and Aphria (APHA).

How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF?

Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FTXH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners